ASCC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.657000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.875800E-01
Normal-vs-Stage2
5.486200E-01
Normal-vs-Stage3
5.261600E-02
Normal-vs-Stage4
2.723800E-01
Stage1-vs-Stage2
6.644000E-01
Stage1-vs-Stage3
3.693400E-01
Stage1-vs-Stage4
7.712400E-01
Stage2-vs-Stage3
1.113810E-01
Stage2-vs-Stage4
4.363800E-01
Stage3-vs-Stage4
5.048800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.967400E-01
Normal-vs-AfricanAmerican
5.909200E-01
Normal-vs-Asian
6.534000E-02
Caucasian-vs-AfricanAmerican
8.463600E-01
Caucasian-vs-Asian
1.054630E-01
AfricanAmerican-vs-Asian
1.615160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.037800E-01
Normal-vs-Female
5.220200E-01
Male-vs-Female
8.585200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.344000E-01
Normal-vs-Age(41-60Yrs)
9.292800E-01
Normal-vs-Age(61-80Yrs)
2.397000E-01
Normal-vs-Age(81-100Yrs)
1.458180E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.520400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.151600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.958400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.022400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.920100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.614400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.354400E-01
Normal-vs-Daily Drinker
4.805000E-01
Normal-vs-Weekly Drinker
1.688420E-01
Normal-vs-Occasional Drinker
4.624000E-01
Normal-vs-Social Drinker
9.555800E-01
Non Drinker-vs-Daily Drinker
9.611600E-01
Non Drinker-vs-Weekly Drinker
5.649200E-01
Non Drinker-vs-Occasional Drinker
7.604000E-01
Non Drinker-vs-Social Drinker
3.299400E-01
Daily Drinker-vs-Weekly Drinker
6.423000E-01
Daily Drinker-vs-Occasional Drinker
7.103200E-01
Daily Drinker-vs-Social Drinker
3.160600E-01
Weekly Drinker-vs-Occasional Drinker
3.191800E-01
Weekly Drinker-vs-Social Drinker
1.759210E-01
Occasional Drinker-vs-Social Drinker
4.638800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.995200E-01
Normal-vs-Grade 2
5.098100E-02
Normal-vs-Grade 3
7.088400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.764600E-03
Grade 1-vs-Grade 3
1.024250E-03
Grade 1-vs-Grade 4
2.995200E-01
Grade 2-vs-Grade 3
9.586500E-02
Grade 2-vs-Grade 4
5.098100E-02
Grade 3-vs-Grade 4
7.088400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.141000E-01
Normal-vs-NonDiabetic
5.147600E-01
Diabetic-vs-NonDiabetic
4.025600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.995000E-01
Normal-vs-NoPancreatitis
3.944200E-01
Pancreatitis-vs-NoPancreatitis
1.552240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.268400E-01
Normal-vs-N1
5.323400E-01
N0-vs-N1
3.040000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.871600E-01
Normal-vs-TP53-NonMutant
4.007800E-01
TP53-Mutant-vs-TP53-NonMutant
3.386300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
